Fulton Breakefield Broenniman Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$6.03M |
| 2 |
UnitedHealth
UNH
|
+$5.81M |
| 3 |
CERN
Cerner Corp
CERN
|
+$4.96M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$4.4M |
| 5 |
Apple
AAPL
|
+$4.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$5.8M |
| 2 |
Elevance Health
ELV
|
+$4.61M |
| 3 |
CELG
Celgene Corp
CELG
|
+$3.26M |
| 4 |
Walmart Inc
WMT
|
+$2.74M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.22% |
| 2 | Healthcare | 13.18% |
| 3 | Consumer Staples | 10.82% |
| 4 | Technology | 9.75% |
| 5 | Financials | 9.24% |
Similar funds
Fulton Breakefield Broenniman's Q2 2015 Portfolio in Review
As of Q2 2015, Fulton Breakefield Broenniman held 135 positions worth $457M, up 1.8% from $449M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fulton Breakefield Broenniman deployed $16.1M of net new capital in Q2 2015, opening 8 new positions and adding to 72 existing holdings. Its largest new stake was Danaher: 105,236 shares worth $6.05M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Procter & Gamble, an estimated $257K trimmed.
- Fulton Breakefield Broenniman's largest Q2 2015 buy was Danaher: 105,236 shares worth $6.05M.
- Fulton Breakefield Broenniman added most to Apple in Q2 2015, an estimated $4.26M increase.
- Fulton Breakefield Broenniman's biggest Q2 2015 reduction was Procter & Gamble, cutting an estimated $257K.
- Fulton Breakefield Broenniman fully exited Emerson Electric in Q2 2015, selling an estimated $5.8M.
- Fulton Breakefield Broenniman's ten largest holdings make up 20% of its $457M portfolio in Q2 2015.
- Fulton Breakefield Broenniman opened 8 new positions and closed 13 in Q2 2015.
- Fulton Breakefield Broenniman's portfolio value rose 1.8% quarter-over-quarter to $457M.
Based on Fulton Breakefield Broenniman's 13F filing for Q2 2015, filed 4 Aug 2015.